Aktuellt
SENASTE
Redeye maintains a positive view of Northbaze, even in the face of a substantial sales contraction. While the company proactively addresses the reduced demand, the prevailing macroeconomic challenges continue to impact Northbaze’s top and bottom-line performance. Despite a challenging quarter, Northbaze is steadfast in its pursuit of recuperating and upholding a 10% EBITDA margin in 2023. Our view on Northbaze remains unchanged, leading us to maintain our existing fair-value range and base case.
LÄS MER
